Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Robot-assisted vs. Open Nipple-sparing Mastectomy With Immediate Breast Reconstruction 08/05/2022 INTERVENTIONAL unchanged 1,482.85 0 Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation 08/08/2022 INTERVENTIONAL unchanged 1,479.85 0 Hypofractionated Radiotherapy in Breast Cancer Patients With Prosthetic Reconstruction 08/08/2022 INTERVENTIONAL unchanged 1,479.85 0 Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer 08/08/2022 INTERVENTIONAL unchanged 1,479.85 0 The Heartland Study 08/08/2022 OBSERVATIONAL unchanged 1,479.85 0 Transvaginal NOSES Versus Conventional Laparoscopic Surgery for Right Hemicolectomy 08/10/2022 INTERVENTIONAL unchanged 1,477.85 0 A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV 08/10/2022 INTERVENTIONAL unchanged 1,477.85 0 Neuroplasticity in Maternal Opioid Use Disorder (OUD) 08/10/2022 INTERVENTIONAL unchanged 1,477.85 0 Investigate the Contribution of Ipatasertib to Neoadjuvant Chemotherapy Plus Atezolizumab in TNBC 08/12/2022 INTERVENTIONAL unchanged 1,475.85 0 The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART) 08/12/2022 INTERVENTIONAL unchanged 1,475.85 0 Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU 08/12/2022 OBSERVATIONAL unchanged 1,475.85 0 PlacEntal Acute Atherosis RefLecting Subclinical Atherosclerosis 08/15/2022 OBSERVATIONAL unchanged 1,472.85 0 Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application 08/16/2022 INTERVENTIONAL unchanged 1,471.85 0 The Lullaby Project as a Musical Intervention for Pregnant Individuals With Epilepsy 08/16/2022 INTERVENTIONAL unchanged 1,471.85 0 Born In Guangzhou Intervention Study 08/17/2022 INTERVENTIONAL unchanged 1,470.85 0 MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing 08/17/2022 INTERVENTIONAL unchanged 1,470.85 0 Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST) 08/17/2022 INTERVENTIONAL unchanged 1,470.85 0 Cryoablation vs Lumpectomy in T1 Breast Cancers 08/18/2022 INTERVENTIONAL unchanged 1,469.85 0 Prone Positioning During Delayed Cord Clamping 08/19/2022 INTERVENTIONAL unchanged 1,468.85 0 Exploring Central Sensitization in Pregnant Women 08/19/2022 OBSERVATIONAL unchanged 1,468.85 0 Clinical Outcomes and Patient Satisfaction With Use of the Amma System 08/19/2022 OBSERVATIONAL unchanged 1,468.85 0 Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement 08/22/2022 INTERVENTIONAL unchanged 1,465.85 0 Uterine Microbiome in Recurrent Pregnancy Loss 08/22/2022 OBSERVATIONAL unchanged 1,465.85 0 Efficacy of Acupuncture Treatment for Breast Cancer-associated Insomnia 08/22/2022 INTERVENTIONAL unchanged 1,465.85 0 Tislelizumab Combined With Concurrent Chemoradiotherapy as First-line Treatment for Stage IIIC2 Cervical Cancer 08/23/2022 INTERVENTIONAL unchanged 1,464.85 0 Reduced-dose Botox for Urgency Incontinence Among Elder Females 08/23/2022 INTERVENTIONAL unchanged 1,464.85 0 A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib 08/23/2022 INTERVENTIONAL unchanged 1,464.85 0 Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction 08/23/2022 INTERVENTIONAL unchanged 1,464.85 0 Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin 08/24/2022 OBSERVATIONAL unchanged 1,463.85 0 Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients 08/24/2022 INTERVENTIONAL unchanged 1,463.85 0 Smoking Cessation and Menstrual Cycle Phase 08/25/2022 INTERVENTIONAL unchanged 1,462.85 0 Weight Loss and Physical Fitness Following Pregnancy in Active Duty Women 08/26/2022 INTERVENTIONAL unchanged 1,461.85 0 Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA 08/29/2022 INTERVENTIONAL unchanged 1,458.85 0 Together Everyone Achieves More (TEAM) Trial 08/29/2022 INTERVENTIONAL unchanged 1,458.85 0 Water and Land-based Aerobic Training in Breast Cancer Survivors 08/30/2022 INTERVENTIONAL unchanged 1,457.85 0 Impact of First-trimester Preeclampsia Screening on Perinatal and Maternal Morbidity (RANSPRE) 08/30/2022 INTERVENTIONAL unchanged 1,457.85 0 Cardio-Oncology Rehabilitation Exercise 08/31/2022 OBSERVATIONAL unchanged 1,456.85 0 A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms 09/02/2022 INTERVENTIONAL unchanged 1,454.85 0 Virtual Reality Mindfulness Meditation After ACL Reconstruction 09/02/2022 INTERVENTIONAL unchanged 1,454.85 0 First in Human Study of IMGN151 in Recurrent Gynaecological Cancers 09/02/2022 INTERVENTIONAL unchanged 1,454.85 0 Trans-RosaLEE Study: a Biomarker-directed, Translational Study 09/07/2022 INTERVENTIONAL unchanged 1,449.85 0 Eribulin With or Without Trastuzumab-biosimilar in Patients With HER2-overexpressed Recurrent or Stage IV Breast Cancer 09/07/2022 INTERVENTIONAL unchanged 1,449.85 0 Appetitive Conditioning in Anorexia Nervosa 09/08/2022 OBSERVATIONAL unchanged 1,448.85 0 Internet CBT for Antenatal Depression 09/08/2022 INTERVENTIONAL unchanged 1,448.85 0 The Oklahoma Parent-Child Assistance Program 09/09/2022 INTERVENTIONAL unchanged 1,447.85 0 Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women 09/10/2022 INTERVENTIONAL unchanged 1,446.85 0 TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients 09/10/2022 INTERVENTIONAL unchanged 1,446.85 0 UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases 09/10/2022 INTERVENTIONAL unchanged 1,446.85 0 WAKIX® (Pitolisant) Pregnancy Registry 09/10/2022 OBSERVATIONAL unchanged 1,446.85 0 Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog) 09/13/2022 INTERVENTIONAL unchanged 1,443.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology